Feng Jiang | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Feng Jiang | Cardiovascular Pharmacology | Best Researcher Award

Stanford University | United States

Dr. Feng Jiang is a highly accomplished postdoctoral researcher at Stanford University, specializing in uncovering the mechanisms and risk factors of human autoimmune diseases. His research focuses on performing experiments and bioinformatic analyses on genetic and RNA-seq data to identify key disease mechanisms and develop therapeutics targeting these pathways. He has also established predictive models based on risk factors to enable early diagnosis of autoimmune conditions. Prior to his postdoctoral work, Dr. Jiang completed his Ph.D. at the University of Rochester, where he conducted extensive research targeting profibrotic genes to combat cardiac fibrosis. His work involved identifying common regulators controlling the expression of profibrotic genes, inhibiting their activity in animal models, and exploring the regulation of mRNA translation in cancer and heart disease. Additionally, he investigated the role of microRNAs in disease, identifying key microRNAs involved in disease progression and their potential as biomarkers for diagnosis and monitoring.Dr. Jiang also gained international research experience as a research fellow at Yat-sen University, where he executed sequencing library construction and established analysis pipelines for human and mouse samples. During his undergraduate studies at Wuhan University, he investigated the role of the gene GLIS2 in cancer progression using CRISPR/Cas9 gene editing techniques.He has contributed significantly to the scientific literature with numerous impactful publications, including works such as RNA Binding Protein PRRC2B Mediates Translation of Specific mRNAs and Regulates Cell Cycle Progression, Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis, Mammalian RNA Switches: Molecular Rheostats in Gene Regulation, Disease, and Medicine, MicroRNA574 Regulates FAM210A Expression and Influences Pathological Cardiac Remodeling, Correlation Between Severity of Spinal Stenosis and Multifidus Atrophy in Degenerative Lumbar Spinal Stenosis, Usage of Procalcitonin and sCD14-ST as Diagnostic Markers for Postoperative Spinal Infection, Correlations Between Serum P2X7, Vitamin A, 25-Hydroxy Vitamin D, and Mycoplasma Pneumoniae Pneumonia, Disruption of Tdrd5 Decouples the Stepwise Processing of Long Precursor Transcripts During Pachytene PIWI-Interacting RNA Biogenesis, and Cardiomyocyte-Specific Loss of Glutamyl-Prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy.

Profile: Google Scholar

Featured Publications

Jiang, F., Hedaya, O. M., Khor, E. S., Wu, J., Auguste, M., & Yao, P. (n.d.). RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression. Nucleic Acids Research.

Wu, J., Subbaiah, K. C. V., Xie, L. H., Jiang, F., Khor, E. S., Mickelsen, D., Myers, J. R., Tang, W. H. W., & Yao, P. (n.d.). Glutamyl-prolyl-tRNA synthetase regulates proline-rich pro-fibrotic protein synthesis during cardiac fibrosis. Circulation Research.

Wu, J., Subbaiah, K. C. V., Jiang, F., Hedaya, O., Mohan, A., Yang, T., Welle, K., Ghaemmaghami, S., Tang, W. H. W., Small, E., Yan, C., & Yao, P. (n.d.). MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodeling. EMBO Molecular Medicine.

Subbaiah, K. C. V., Hedaya, O., Wu, J., Jiang, F., & Yao, P. (n.d.). Mammalian RNA switches: Molecular rheostats in gene regulation, disease, and medicine. Computational and Structural Biotechnology Journal.

Hedaya, O. M., Venkata Subbaiah, K. C., Jiang, F., Xie, L. H., Wu, J., Khor, E. S., Zhu, M., Mathews, D. H., Proschel, C., & Yao, P. (n.d.). Secondary structures that regulate mRNA translation provide insights for ASO-mediated modulation of cardiac hypertrophy. Nature Communications.

Xia, G., Li, X., Shang, Y., Fu, B., Jiang, F., Liu, H., & Qiao, Y. (n.d.). Correlation between severity of spinal stenosis and multifidus atrophy in degenerative lumbar spinal stenosis. BMC Musculoskeletal Disorders.

Zhu, X., Li, K., Zheng, J., Xia, G., Jiang, F., Liu, H., & Shi, J. (n.d.). Usage of procalcitonin and sCD14-ST as diagnostic markers for postoperative spinal infection. Journal of Orthopaedics and Traumatology.

Li, W., Li, Y., Jiang, F., & Liu, H. (n.d.). Correlation between serum levels of microRNA-21 and inflammatory factors in patients with chronic heart failure. Medicine.

Aleksandra Klisic | Cardiovascular Pharmacology | Best Research Article Award

Published on by Top Pharmaceutical

Assoc. Prof. Dr. Aleksandra Klisic | Cardiovascular Pharmacology | Best Research Article Award

University of Montenegro-Faculty of Medicine | Montenegro

Assoc. Prof. Dr. Aleksandra Klisic is a distinguished medical scientist and academic leader from Montenegro, currently serving as an Associate Professor at the University of Montenegro, Faculty of Medicine, Podgorica. She also holds prominent positions as Chief and Quality Manager at the Center for Laboratory Diagnostics, Primary Health Care Center in Podgorica. With a strong foundation in clinical biochemistry and laboratory medicine, she has made significant contributions to the fields of endocrinology, diabetes, oxidative stress, and metabolic disorders.Dr. Klisic’s academic journey began at the University of Belgrade, where she earned her Doctor’s degree, Master’s degree, and Board Certification in Clinical Biochemistry. Her post-graduate specialization in Laboratory Endocrinology further strengthened her expertise in diagnostic and biochemical sciences. She has undergone advanced international training in biosafety, biosecurity, and laboratory leadership under global health programs organized in collaboration with the World Health Organization.Her research focuses on understanding the molecular and biochemical mechanisms underlying metabolic and cardiovascular diseases, emphasizing oxidative stress, inflammation, and hormonal regulation. Through her multidisciplinary studies, she explores the complex interactions between biochemical pathways and disease development, contributing to evidence-based laboratory and clinical practices.Dr. Klisic’s publications are widely recognized in high-impact scientific journals, reflecting her dedication to advancing clinical and translational research. Her work includes groundbreaking studies such as Association of Low Free T3 with Disease Presence and Activity in Ankylosing Spondylitis, Relationship Between Oxidative Stress and Cardiovascular Risk in Adolescents in Montenegro, SGLT2 Inhibitors and Cardiac Fibrosis: A Comprehensive Review, Role of Interleukins in Type 1 and Type 2 Diabetes, Oxidative Stress in Adolescents with Overweight/Obesity, and Association of Serum Selenium with Pro-atherogenic Adhesion Molecules, Inflammatory Cytokines and Carotid Intima-Media Thickness in Patients with Metabolic Syndrome. Her book chapter Antioxidant Supplementation and Cardiometabolic Syndrome (Elsevier) demonstrates her scholarly contribution to understanding reactive oxygen species and their role in chronic diseases.

Profile: Orcid

Featured Publications

Ciftel, E., Klisic, A., Kizilkaya, B., Cure, O., Mercantepe, F., Mataraci Karakas, S., & Ninić, A. (n.d.). Association of low free T3 with disease presence and activity in ankylosing spondylitis. International Journal of Molecular Sciences.

Klisic, A., Bozovic, M., Ostanek, B., Marc, J., Karakasis, P., Mercantepe, F., & Kotur-Stevuljevic, J. (n.d.). Relationship between oxidative stress and cardiovascular risk in adolescents in Montenegro. International Journal of Molecular Sciences.

Veljkovic, A., Stanojevic, G., Brankovic, B., Roumeliotis, S., Leivaditis, K., Djordjevic, B., Li, X., Klisic, A., Hadzi-Djokic, J., & Kocic, G. (n.d.). MMP-9 activation via ROS/NF-κB signaling in colorectal cancer progression: Molecular insights and prognostic–therapeutic perspectives. Current Issues in Molecular Biology.

Asif, R., Khalid, A., Mercantepe, T., Klisic, A., Rafaqat, S., Rafaqat, S., & Mercantepe, F. (n.d.). Role of interleukins in type 1 and type 2 diabetes. Diagnostics.

Pishdadian, A., Sharifi, R., Shafaghi, A., Hamedi-Shahraki, S., Amirkhizi, F., & Klisic, A. (n.d.). Association of serum selenium with clinical features and inflammatory and oxidative stress markers in Iranian patients with metabolic dysfunction-associated steatotic liver disease—A cross-sectional study. Diagnostics.

Erceg, S., Munjas, J., Sopić, M., Tomašević, R., Mitrović, M., Kotur-Stevuljević, J., Mamić, M., Vujčić, S., Klisic, A., & Ninić, A. (n.d.). Expression analysis of circulating miR-21, miR-34a and miR-122 and redox status markers in metabolic dysfunction-associated steatotic liver disease patients with and without type 2 diabetes. International Journal of Molecular Sciences.

Samavarchitehrani, A., Mercantepe, F., Behnoush, A. H., & Klisic, A. (n.d.). Exploring the TyG index and the homeostasis model assessment of insulin resistance as insulin resistance markers: Implications for fibromyalgia management and understanding—A narrative review. Diagnostics.

Ćeriman Krstić, V., Jovanović, D., Samardžić, N., Gajić, M., Kotur Stevuljević, J., Klisic, A., Soldatović, I., Radončić, D., Roksandić Milenković, M., & Šeha, B. (n.d.). The potential role of sPD-L1 as a predictive biomarker in EGFR-positive non-small-cell lung cancer. Current Issues in Molecular Biology.